Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity.

Martinez-Garcia MÁ, Athanazio R, Gramblicka G, Corso M, Cavalcanti Lundgren F, Fernandes de Figueiredo M, Arancibia F, Rached S, Girón R, Máiz Carro L, de la Rosa Carrillo D, Prados C, Olveira C.

Arch Bronconeumol. 2018 Aug 14. pii: S0300-2896(18)30291-6. doi: 10.1016/j.arbres.2018.07.002. [Epub ahead of print] English, Spanish.

2.

High risk of subclinical atherosclerosis in COPD exacerbator phenotype.

Domenech A, Muñoz-Montiel A, García-Casares N, Rioja J, Ruiz-Esteban P, Gutierrez-Castaño P, Prunera Pardell MJ, Olveira C, Valdivielso P, Sánchez-Chaparro MÁ.

Respir Med. 2018 Aug;141:165-171. doi: 10.1016/j.rmed.2018.07.004. Epub 2018 Jul 17.

PMID:
30053963
3.

Pulmonary Rehabilitation Only Versus With Nutritional Supplementation in Patients With Bronchiectasis: A RANDOMIZED CONTROLLED TRIAL.

Doña E, Olveira C, Palenque FJ, Porras N, Dorado A, Martín-Valero R, Godoy AM, Espildora F, Olveira G.

J Cardiopulm Rehabil Prev. 2018 Jun 26. doi: 10.1097/HCR.0000000000000341. [Epub ahead of print]

PMID:
29952809
4.

Body Composition Measurement in Bronchiectasis: Comparison between Bioelectrical Impedance Analysis, Skinfold Thickness Measurement, and Dual-Energy X-ray Absorptiometry before and after Pulmonary Rehabilitation.

Doña E, Olveira C, Palenque FJ, Porras N, Dorado A, Martín-Valero R, Godoy AM, Espíldora F, Contreras V, Olveira G.

J Acad Nutr Diet. 2018 Aug;118(8):1464-1473. doi: 10.1016/j.jand.2018.01.013. Epub 2018 Apr 12.

PMID:
29656933
5.

Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.

Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, Rivas-Ruiz F, Carmona-Olveira A, Cebrian-Gallardo JJ, Martinez-Garcia MA.

Respir Res. 2018 Mar 16;19(1):43. doi: 10.1186/s12931-018-0746-7.

6.

The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.

de la Rosa Carrillo D, Athanazio R, Girón Moreno RM, Máiz Carro L, Olveira C, de Gracia J, Vendrell M, Prados Sánchez C, Gramblicka G, Corso Pereira M, Lundgren F, Fernandes De Figueiredo M, Arancibia F, Rached S, Martínez-Garcia MA.

ERJ Open Res. 2018 Mar 6;4(1). pii: 00139-2017. doi: 10.1183/23120541.00139-2017. eCollection 2018 Jan.

7.

Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult): New tool for monitoring psychosocial health in CF.

Solé A, Olveira C, Pérez I, Hervás D, Valentine V, Baca Yepez AN, Olveira G, Quittner AL.

J Cyst Fibros. 2018 Sep;17(5):672-679. doi: 10.1016/j.jcf.2017.10.015. Epub 2017 Nov 20.

PMID:
29157922
8.

Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):79-87. doi: 10.1016/j.arbres.2017.07.015. Epub 2017 Nov 9. English, Spanish.

9.

Spanish Guidelines on Treatment of Bronchiectasis in Adults.

Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, Cantón R, Vendrell M, Polverino E, de Gracia J, Prados C.

Arch Bronconeumol. 2018 Feb;54(2):88-98. doi: 10.1016/j.arbres.2017.07.016. Epub 2017 Nov 9. English, Spanish.

10.

Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.

López-Causapé C, de Dios-Caballero J, Cobo M, Escribano A, Asensio Ó, Oliver A, Del Campo R, Cantón R, Solé A, Cortell I, Asensio O, García G, Martínez MT, Cols M, Salcedo A, Vázquez C, Baranda F, Girón R, Quintana E, Delgado I, de Miguel MÁ, García M, Oliva C, Prados MC, Barrio MI, Pastor MD, Olveira C, de Gracia J, Álvarez A, Escribano A, Castillo S, Figuerola J, Togores B, Oliver A, López C, de Dios Caballero J, Tato M, Máiz L, Suárez L, Cantón R.

Int J Antimicrob Agents. 2017 Sep;50(3):334-341. doi: 10.1016/j.ijantimicag.2017.03.034. Epub 2017 Jul 20.

PMID:
28735882
11.

Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.

Olveira C, Padilla A, Dorado A, Contreras V, Garcia-Fuentes E, Rubio-Martin E, Porras N, Doña E, Carmona A, Olveira G.

Eurasian J Med. 2017 Jun;49(2):118-123. doi: 10.5152/eurasianjmed.2017.17010.

12.

Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.

De la Rosa D, Martínez-Garcia MA, Giron RM, Vendrell M, Olveira C, Borderias L, Maiz L, Torres A, Martinez-Moragon E, Rajas O, Casas F, Cordovilla R, de Gracia J.

PLoS One. 2017 May 18;12(5):e0177931. doi: 10.1371/journal.pone.0177931. eCollection 2017.

13.

Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity.

Olveira C, Martínez-García MA.

Eur Respir J. 2017 May 11;49(5). pii: 1700208. doi: 10.1183/13993003.00208-2017. Print 2017 May. No abstract available.

PMID:
28495696
14.

Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts.

Athanazio R, Pereira MC, Gramblicka G, Cavalcanti-Lundgren F, de Figueiredo MF, Arancibia F, Rached S, de la Rosa D, Máiz-Carro L, Girón R, Olveira C, Prados C, Martinez-Garcia MA.

BMC Pulm Med. 2017 Apr 26;17(1):73. doi: 10.1186/s12890-017-0417-3.

15.

Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.

Girón RM, de Gracia Roldán J, Olveira C, Vendrell M, Martínez-García MÁ, de la Rosa D, Máiz L, Ancochea J, Vázquez L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Soriano JB.

Chron Respir Dis. 2017 Nov;14(4):360-369. doi: 10.1177/1479972317702139. Epub 2017 Apr 10.

16.

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.

Martinez-Garcia MA, Athanazio RA, Girón R, Máiz-Carro L, de la Rosa D, Olveira C, de Gracia J, Vendrell M, Prados-Sánchez C, Gramblicka G, Corso Pereira M, Lundgren FL, Fernandes De Figueiredo M, Arancibia F, Rached SZ.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 18;12:275-284. doi: 10.2147/COPD.S121943. eCollection 2017.

17.

Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry.

Olveira C, Padilla A, Martínez-García MÁ, de la Rosa D, Girón RM, Vendrell M, Máiz L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Casas F, Cordovilla R, de Gracia J.

Arch Bronconeumol. 2017 Jul;53(7):366-374. doi: 10.1016/j.arbres.2016.12.003. Epub 2017 Jan 21. English, Spanish.

18.

Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.

Máiz L, Girón R, Olveira C, Vendrell M, Nieto R, Martínez-García MA.

BMC Infect Dis. 2016 Aug 22;16(1):437. doi: 10.1186/s12879-016-1774-x.

19.

The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.

Martínez-García MÁ, Vendrell M, Girón R, Máiz-Carro L, de la Rosa Carrillo D, de Gracia J, Olveira C.

Ann Am Thorac Soc. 2016 Sep;13(9):1468-75. doi: 10.1513/AnnalsATS.201510-678OC.

PMID:
27348199
20.

Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.

de la Rosa D, Martínez-Garcia MA, Olveira C, Girón R, Máiz L, Prados C.

Chron Respir Dis. 2016 Nov;13(4):361-371. doi: 10.1177/1479972316643698. Epub 2016 Jul 7.

Supplemental Content

Loading ...
Support Center